Managing Director

Johan Eykens

Expertise

​

For more than 25 years I have been active in the health care sector, representing companies, promoting products with competent authorities, academics, health funds and healthcare professionals. Learning from, interacting with and sharing expertise with these stakeholders are the basis of the engagement process leading to access of new therapies to patients, the essence of our work. As a former member of the Belgian Medicines Reimbursement Committee and former chair at the Federal Agency of Medicines, I value the close collaboration with Health Care Authorities. As a Vice-President of the Council of Local Economy of Tervuren, I share my professional expertise with fellow citizens to create a lively and dynamic community.

​

Qualifications

​

• Pharmacist – KU Leuven

• Master of Science in Pharmacology – University of Bradford (UK) 

• Postgraduate in Business Administration – KU Leuven  

Career summary

​

• 2002 – present: Managing Director of E&A Farma

• Management positions with Merck-Serono, EG, MSD and Leo Pharma 

Market Access Consultant

Sofie Verhaegen

Expertise

​

I became really passionate about the pricing and reimbursement environment when I was still in university. I had the opportunity to do an internship at Pfizer in market access. After working in the regulatory environment, I Joined E&A consultants in 2018.

Market access is really the last step to give the patient access to their medication. I think a really important message in our job, and moreover our goal is to make the healthcare system more accessible for every one of us.

Within this mindset, I’m really interested in the pricing and reimbursement environment.  Working together as a team is one of the key elements for success in market access.

​

Qualifications

​

• 2017: Master in pharmaceutical sciences at the KULeuven

• 2020 - present: Master of Health Care Management and Policy at the KULeuven

​

Career summary

​

• 2018 - present: Market Access Consultant at E&A Farma

• 2017-2018: Regulatory Affairs Officer at EG

• 2016-2017: Market Access Internship at Pfizer

I Lisa THYRION   I

Expertise

​

A strong interest in therapeutic innovation sparked me to study biotechnology and pursue a PhD in medical sciences. After completing my PhD, I switched to the pharmaceutical sector in look of a stronger focus on patient welfare, in which I strengthened medical teams in the fields of respiratory care and rare diseases. The close collaboration with market access during this period spiked my interest in pricing and reimbursement as a key element of delivering healthcare to the patient. I am delighted to now be part of the e&a team to contribute to dossiers that help making a difference at this crucial level.

​

Qualifications

​

• 2016: PhD in Medical Sciences at Ghent University

• 2011: Master in Biochemistry & Biotechnology at Ghent University

​

​Career summary

​

• 2019- present: Market Access Officer at E&A Farma

• 2019: Medical Science Liaison Belux Rare Diseases at Kyowa Kirin

• 2016-2018: Medical Advisor Respiratory Care at Chiesi

​​

Senior Associate Consultant

Lisa Thyrion

Expertise

​

During my studies at the KU Leuven, I developed a strong interest in the Health Economic environment and pricing and reimbursement. Later, this interest was again emphasized throughout my internship at MSD Belgium in the Market Access department.

My professional career started in Clinical Research. In 2021, I joined E&A consultants to pursue my interest in Pricing and Reimbursement. At E&A, I want to make a difference for every patient and facilitate and optimize their access to medicines.

​​

​Qualifications

​

• 2020: Master in Pharmaceutical Sciences at KU Leuven

​

​Career summary

​

• 2021 - Present: Market Access Officer at E&A Farma

• 2020: Site Activation Specialist at PRA Health Sciences

• 2019-2020: Market Access Internship at MSD Belgium

​​

Associate Consultant

Roeland Willems

Market Access Intern
Andrea Verdoodt

Expertise

​

My interest in Market Access was sparked during the courses of Health economics and The Lifecycle of a drug in my first year as a master student in Drug Development at the KU Leuven. I find pricing and reimbursement a critical tipping point for patients to gain access to their medication. The internship at E&A is an ultimate chance to put theory into practice, while gaining soft skills and knowledge of the inner working of the pharmaceutical industry

​​

​Qualifications

​

• 2020 - Present: Master Drug Development (Pharmaceutical Sciences) at KU Leuven

• July 2021: Advanced Clinical Research Monitoring Workshop.

​

​

​​